Sunitinib in Never-Smokers With Lung Adenocarcinoma

NCT01829217 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Sunitinib

Sponsor

Dana-Farber Cancer Institute